Cargando…
Activation of c-Met in cancer cells mediates growth-promoting signals against oxidative stress through Nrf2-HO-1
Any imbalance between reactive oxygen species (ROS) generation and the anti-oxidant capacity lead to cellular oxidative stress. Many chemotherapeutic agents mediate their cytotoxic functions through the generation of ROS. c-Met, a receptor tyrosine kinase, is over-expressed in renal cancer and plays...
Autores principales: | Chakraborty, Samik, Balan, Murugabaskar, Flynn, Evelyn, Zurakowski, David, Choueiri, Toni K., Pal, Soumitro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333845/ https://www.ncbi.nlm.nih.gov/pubmed/30647407 http://dx.doi.org/10.1038/s41389-018-0116-9 |
Ejemplares similares
-
Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth
por: Balan, Murugabaskar, et al.
Publicado: (2017) -
A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress
por: Rawat, Laxminarayan, et al.
Publicado: (2023) -
A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape
por: Sabarwal, Akash, et al.
Publicado: (2020) -
Novel Honokiol-eluting PLGA-based scaffold effectively restricts the growth of renal cancer cells
por: Hamedani, Yasaman, et al.
Publicado: (2020) -
Calcineurin Inhibitor-Induced and Ras-Mediated Overexpression of VEGF in Renal Cancer Cells Involves mTOR through the Regulation of PRAS40
por: Basu, Aninda, et al.
Publicado: (2011)